6 results
Tranexamic Acid - Indications and Pharmacology
Pharmacokinetics:
 • MOA: Inhibits plasminogen activation to plasmin & inhibits fibrinolysis
Indications and Pharmacology ... Inhibits plasminogen activation ... reduces complement activation ... fatigue; Increases risk ... #hematology
In July 2015 the ACC/AHA proposed and published an algorithm to help stratify cardiac arrest patients
and published an algorithm ... CardiacArrest #Algorithm ... #Risk #Stratfication ... #Management #Cardiology ... #CriticalCare
TRALI vs TACO - Transfusion Reactions
TRALI:
 • Epidemiology: 0.1% of transfused patientsl
 • Risk factors: Critical
transfused patientsl • Risk ... sequestration and activation ... without other cause ... transfused patients • Risk ... , and CXR with pulmonary
Sjogren's Syndrome Overview

Epidemiology:
• F > M: 9:1
• 5-6th Decades (can be any age)

Autoimmune exocrinopathy multisystemic disease
effusion, INC risk ... PE, Pulmonary amyloidosis ... Nephrogenic DI Hematologic ... Malignancy Risk ... lubricants • Pharmacologic
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
with presence of pulmonary ... the determined cause ... #differential #algorithm ... #management #cardiology ... icu #clinical #pharmacology
Cryptococcal meningitis on T2 MRI
30 M from sub-Saharan Africa presents w/ progressive Headache x1 mo, +neck
& results from reactivation ... of prior silent pulmonary ... Nausea & vomiting ... performed, relative risk ... have a higher risk